المؤلفون: Rainer Krahl, Thoralf Lange, Dietger Niederwieser, Christian Niederwieser, Ulrich von Grünhagen, Volker Lakner, Markus Pfirrmann, Kathleen Jentsch-Ullrich, Claudia Spohn, Michael Cross, Haifa Kathrin Al-Ali, Arthur Gil, Rüdiger Hehlmann, Christian Junghanss, Michael Assmann, Michael W. Deininger

المصدر: Leukemia & Lymphoma. 61:2821-2830

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Antineoplastic Agents, Chronic myeloid leukaemia, German, 03 medical and health sciences, 0302 clinical medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Hydroxyurea, neoplasms, business.industry, Imatinib, Hematology, medicine.disease, language.human_language, Phase i study, Treatment Outcome, 030220 oncology & carcinogenesis, Chronic Disease, Imatinib Mesylate, language, business, 030215 immunology, Chronic myelogenous leukemia, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d4746fe84a79cad43227efb4e177ca7
https://doi.org/10.1080/10428194.2020.1786556

المؤلفون: Michael Herold, Volker Lakner, Carsten Hirt, Christian Scholz, Frank Rothmann, Ralph Naumann

المصدر: Journal of Cancer Research and Clinical Oncology. 141:1689-1695

مصطلحات موضوعية: Adult, Oncology, Cancer Research, medicine.medical_specialty, Prednisolone, medicine.medical_treatment, Follicular lymphoma, Alpha interferon, Maintenance therapy, immune system diseases, hemic and lymphatic diseases, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Prospective Studies, Lymphoma, Follicular, Aged, Chemotherapy, Mitoxantrone, Chlorambucil, business.industry, General Medicine, Middle Aged, medicine.disease, Immunology, Rituximab, business, Follow-Up Studies, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51bb152fe6998d06ef7fafa0d493415e
https://doi.org/10.1007/s00432-015-1963-9

المؤلفون: Gerd Müller, Michael Koenigsmann, Rainer Bartsch, Christoph Kahl, Michael Herold, Henning Eschenburg, Martin Mohren, Kathleen Jentsch-Ullrich, Rita Pasold, Astrid Franke, Volker Lakner, W. U. Knauf, Michael Assmann

المصدر: Leukemia & Lymphoma. 45:1821-1827

مصطلحات موضوعية: Adult, Male, Oncology, Bendamustine, Cancer Research, medicine.medical_specialty, Time Factors, Lymphoma, medicine.medical_treatment, Follicular lymphoma, Neutropenia, Medical Oncology, Recurrence, Germany, Internal medicine, medicine, Bendamustine Hydrochloride, Humans, Societies, Medical, Aged, Neoplasm Staging, Chemotherapy, Hematology, business.industry, Remission Induction, Middle Aged, medicine.disease, Fludarabine, Regimen, Nitrogen Mustard Compounds, Female, Mantle cell lymphoma, business, Vidarabine, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47e8ba8db61e28aaf865f2375e1f2fa7
https://doi.org/10.1080/1042819042000223822

المؤلفون: Jens Stieler, Uwe Pelzer, Tim F. Greten, Jörg Seraphin, Volker Lakner, Gerhard Heil, Ingo Schwaner, Helmut Oettle, Hanno Riess, Martin Görner, Sven Bischoff, Marianne Sinn, Matthias Mölle, Bernd Dörken

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(23)

مصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Organoplatinum Compounds, Leucovorin, Deoxycytidine, law.invention, Folinic acid, Randomized controlled trial, law, Pancreatic cancer, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Medicine, Humans, Aged, Aged, 80 and over, business.industry, Middle Aged, medicine.disease, Survival Analysis, Gemcitabine, Oxaliplatin, Clinical trial, Pancreatic Neoplasms, Regimen, Treatment Outcome, Fluorouracil, Drug Resistance, Neoplasm, Disease Progression, Female, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4962d6c54afbde9aaddd5ec8b839e9b5
https://pubmed.ncbi.nlm.nih.gov/25027593

المؤلفون: Axel Hinke, Volker Lakner, Hans-Joachim Hindenburg, Nikola Bangemann, G. Schaller, Peter Klare, Anke Kleine-Tebbe, I. Fuchs, Thomas Gonsch, Jan Weber

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(22)

مصطلحات موضوعية: Oncology, Adult, Cancer Research, medicine.medical_specialty, Antimetabolites, Antineoplastic, Receptor, ErbB-2, Phases of clinical research, Breast Neoplasms, Antibodies, Monoclonal, Humanized, Loading dose, Deoxycytidine, Metastasis, Capecitabine, Breast cancer, Trastuzumab, Internal medicine, Germany, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Anthracyclines, Survival rate, Aged, business.industry, Antibodies, Monoclonal, Middle Aged, medicine.disease, Metastatic breast cancer, ErbB Receptors, Survival Rate, Treatment Outcome, Disease Progression, Taxoids, Fluorouracil, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f196767b826a68a3d9cddb542617237
https://pubmed.ncbi.nlm.nih.gov/17577021

المؤلفون: Ursula Haak, Rita Pasold, Sabine Hahnfels, Thomas-Hein Ittel, Christian Klinkenstein, Sabine Neser, Andreas Neubauer, Franz-Adolph Hoffmann, Ullrich von Gruenhagen, Ullrich Mey, Klaus Dachselt, Dorothee Bleyl, Mathias Freund, Ralph Naumann, Klaus Hieke, Heiner Wolf, Erika Kettner, Thomas Fietz, Volker Lakner, Helga Schwenke, Gottfried Doelken, Detlev Haehling, Henning Eschenburg, Klaus Hoeffken, Michael Assmann, Dietger Niederwieser, Michael Herold, Astrid Franke, Norbert Grobe, Robert Rohrberg, Michael R. Clemens, H.-H. Wolf, Peter Richter

المصدر: Blood. 104:87-87

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Immunology, Cell Biology, Hematology, Interim analysis, medicine.disease, Biochemistry, Surgery, Clinical trial, Private practice, Internal medicine, Multicenter trial, medicine, Prednisolone, Rituximab, Adverse effect, business, Progressive disease, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a536e0d79f6fe75281fffe392cf82f12
https://doi.org/10.1182/blood.v104.11.87.87

المؤلفون: Ursula Haak, Astrid Franke, Ullrich Mey, Peter Richter, Rita Pasold, Stefanie Srock, Volker Lakner, Franz-Adolph Hoffmann, Sabine Neser, Gottfried Dölken, Thomas Ittel, Helga Schwenke, Ralph Naumann, Thomas Fietz, Andreas Neubauer, Michael Herold, Robert Rohrberg, Erika Kettner, Norbert Grobe, Mathias Freund, Dietger Niederwieser, Michael Assmann, Christian Klinkenstein, Dorothee Bleyl, Heiner Wolf, Detlev Hähling, Ullrich von Gruenhagen, Michael R. Clemens, H.-H. Wolf, Klaus Dachselt, Sabine Hahnfeld, Henning Eschenburg, Klaus Hoeffken

المصدر: Blood. 104:584-584

مصطلحات موضوعية: medicine.medical_specialty, Chemotherapy, Mitoxantrone, business.industry, medicine.medical_treatment, Immunology, Follicular lymphoma, Cell Biology, Hematology, medicine.disease, Biochemistry, Gastroenterology, Surgery, Non-Hodgkin's lymphoma, hemic and lymphatic diseases, Internal medicine, medicine, Prednisolone, Mantle cell lymphoma, Rituximab, Progression-free survival, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::67cc847416484b206e1117aed57a247e
https://doi.org/10.1182/blood.v104.11.584.584

المؤلفون: Oettle H; Helmut Oettle, Hanno Riess, Jens M. Stieler, Sven Bischoff, Marianne Sinn, Bernd Dörken, and Uwe Pelzer, Charitě Universitätsmedizin; Ingo Schwaner, Clinical Center, Berlin; Helmut Oettle, Clinical Center, Friedrichschafen; Gerhard Heil, Clinical Center, Lüdenscheid; Jörg Seraphin, Clinical Center, Northeim; Martin Görner, Clinical Center, Bielefeld; Matthias Mölle, Clinical Center, Dresden; Tim F. Greten, Hannover Medical School, Hannover; and Volker Lakner, Clinical Center, Rostock, Germany. helmut.oettle@charite.de., Riess H; Helmut Oettle, Hanno Riess, Jens M. Stieler, Sven Bischoff, Marianne Sinn, Bernd Dörken, and Uwe Pelzer, Charitě Universitätsmedizin; Ingo Schwaner, Clinical Center, Berlin; Helmut Oettle, Clinical Center, Friedrichschafen; Gerhard Heil, Clinical Center, Lüdenscheid; Jörg Seraphin, Clinical Center, Northeim; Martin Görner, Clinical Center, Bielefeld; Matthias Mölle, Clinical Center, Dresden; Tim F. Greten, Hannover Medical School, Hannover; and Volker Lakner, Clinical Center, Rostock, Germany., Stieler JM; Helmut Oettle, Hanno Riess, Jens M. Stieler, Sven Bischoff, Marianne Sinn, Bernd Dörken, and Uwe Pelzer, Charitě Universitätsmedizin; Ingo Schwaner, Clinical Center, Berlin; Helmut Oettle, Clinical Center, Friedrichschafen; Gerhard Heil, Clinical Center, Lüdenscheid; Jörg Seraphin, Clinical Center, Northeim; Martin Görner, Clinical Center, Bielefeld; Matthias Mölle, Clinical Center, Dresden; Tim F. Greten, Hannover Medical School, Hannover; and Volker Lakner, Clinical Center, Rostock, Germany., Heil G; Helmut Oettle, Hanno Riess, Jens M. Stieler, Sven Bischoff, Marianne Sinn, Bernd Dörken, and Uwe Pelzer, Charitě Universitätsmedizin; Ingo Schwaner, Clinical Center, Berlin; Helmut Oettle, Clinical Center, Friedrichschafen; Gerhard Heil, Clinical Center, Lüdenscheid; Jörg Seraphin, Clinical Center, Northeim; Martin Görner, Clinical Center, Bielefeld; Matthias Mölle, Clinical Center, Dresden; Tim F. Greten, Hannover Medical School, Hannover; and Volker Lakner, Clinical Center, Rostock, Germany., Schwaner I; Helmut Oettle, Hanno Riess, Jens M. Stieler, Sven Bischoff, Marianne Sinn, Bernd Dörken, and Uwe Pelzer, Charitě Universitätsmedizin; Ingo Schwaner, Clinical Center, Berlin; Helmut Oettle, Clinical Center, Friedrichschafen; Gerhard Heil, Clinical Center, Lüdenscheid; Jörg Seraphin, Clinical Center, Northeim; Martin Görner, Clinical Center, Bielefeld; Matthias Mölle, Clinical Center, Dresden; Tim F. Greten, Hannover Medical School, Hannover; and Volker Lakner, Clinical Center, Rostock, Germany., Seraphin J; Helmut Oettle, Hanno Riess, Jens M. Stieler, Sven Bischoff, Marianne Sinn, Bernd Dörken, and Uwe Pelzer, Charitě Universitätsmedizin; Ingo Schwaner, Clinical Center, Berlin; Helmut Oettle, Clinical Center, Friedrichschafen; Gerhard Heil, Clinical Center, Lüdenscheid; Jörg Seraphin, Clinical Center, Northeim; Martin Görner, Clinical Center, Bielefeld; Matthias Mölle, Clinical Center, Dresden; Tim F. Greten, Hannover Medical School, Hannover; and Volker Lakner, Clinical Center, Rostock, Germany., Görner M; Helmut Oettle, Hanno Riess, Jens M. Stieler, Sven Bischoff, Marianne Sinn, Bernd Dörken, and Uwe Pelzer, Charitě Universitätsmedizin; Ingo Schwaner, Clinical Center, Berlin; Helmut Oettle, Clinical Center, Friedrichschafen; Gerhard Heil, Clinical Center, Lüdenscheid; Jörg Seraphin, Clinical Center, Northeim; Martin Görner, Clinical Center, Bielefeld; Matthias Mölle, Clinical Center, Dresden; Tim F. Greten, Hannover Medical School, Hannover; and Volker Lakner, Clinical Center, Rostock, Germany., Mölle M; Helmut Oettle, Hanno Riess, Jens M. Stieler, Sven Bischoff, Marianne Sinn, Bernd Dörken, and Uwe Pelzer, Charitě Universitätsmedizin; Ingo Schwaner, Clinical Center, Berlin; Helmut Oettle, Clinical Center, Friedrichschafen; Gerhard Heil, Clinical Center, Lüdenscheid; Jörg Seraphin, Clinical Center, Northeim; Martin Görner, Clinical Center, Bielefeld; Matthias Mölle, Clinical Center, Dresden; Tim F. Greten, Hannover Medical School, Hannover; and Volker Lakner, Clinical Center, Rostock, Germany., Greten TF; Helmut Oettle, Hanno Riess, Jens M. Stieler, Sven Bischoff, Marianne Sinn, Bernd Dörken, and Uwe Pelzer, Charitě Universitätsmedizin; Ingo Schwaner, Clinical Center, Berlin; Helmut Oettle, Clinical Center, Friedrichschafen; Gerhard Heil, Clinical Center, Lüdenscheid; Jörg Seraphin, Clinical Center, Northeim; Martin Görner, Clinical Center, Bielefeld; Matthias Mölle, Clinical Center, Dresden; Tim F. Greten, Hannover Medical School, Hannover; and Volker Lakner, Clinical Center, Rostock, Germany., Lakner V; Helmut Oettle, Hanno Riess, Jens M. Stieler, Sven Bischoff, Marianne Sinn, Bernd Dörken, and Uwe Pelzer, Charitě Universitätsmedizin; Ingo Schwaner, Clinical Center, Berlin; Helmut Oettle, Clinical Center, Friedrichschafen; Gerhard Heil, Clinical Center, Lüdenscheid; Jörg Seraphin, Clinical Center, Northeim; Martin Görner, Clinical Center, Bielefeld; Matthias Mölle, Clinical Center, Dresden; Tim F. Greten, Hannover Medical School, Hannover; and Volker Lakner, Clinical Center, Rostock, Germany., Bischoff S; Helmut Oettle, Hanno Riess, Jens M. Stieler, Sven Bischoff, Marianne Sinn, Bernd Dörken, and Uwe Pelzer, Charitě Universitätsmedizin; Ingo Schwaner, Clinical Center, Berlin; Helmut Oettle, Clinical Center, Friedrichschafen; Gerhard Heil, Clinical Center, Lüdenscheid; Jörg Seraphin, Clinical Center, Northeim; Martin Görner, Clinical Center, Bielefeld; Matthias Mölle, Clinical Center, Dresden; Tim F. Greten, Hannover Medical School, Hannover; and Volker Lakner, Clinical Center, Rostock, Germany., Sinn M; Helmut Oettle, Hanno Riess, Jens M. Stieler, Sven Bischoff, Marianne Sinn, Bernd Dörken, and Uwe Pelzer, Charitě Universitätsmedizin; Ingo Schwaner, Clinical Center, Berlin; Helmut Oettle, Clinical Center, Friedrichschafen; Gerhard Heil, Clinical Center, Lüdenscheid; Jörg Seraphin, Clinical Center, Northeim; Martin Görner, Clinical Center, Bielefeld; Matthias Mölle, Clinical Center, Dresden; Tim F. Greten, Hannover Medical School, Hannover; and Volker Lakner, Clinical Center, Rostock, Germany., Dörken B; Helmut Oettle, Hanno Riess, Jens M. Stieler, Sven Bischoff, Marianne Sinn, Bernd Dörken, and Uwe Pelzer, Charitě Universitätsmedizin; Ingo Schwaner, Clinical Center, Berlin; Helmut Oettle, Clinical Center, Friedrichschafen; Gerhard Heil, Clinical Center, Lüdenscheid; Jörg Seraphin, Clinical Center, Northeim; Martin Görner, Clinical Center, Bielefeld; Matthias Mölle, Clinical Center, Dresden; Tim F. Greten, Hannover Medical School, Hannover; and Volker Lakner, Clinical Center, Rostock, Germany., Pelzer U; Helmut Oettle, Hanno Riess, Jens M. Stieler, Sven Bischoff, Marianne Sinn, Bernd Dörken, and Uwe Pelzer, Charitě Universitätsmedizin; Ingo Schwaner, Clinical Center, Berlin; Helmut Oettle, Clinical Center, Friedrichschafen; Gerhard Heil, Clinical Center, Lüdenscheid; Jörg Seraphin, Clinical Center, Northeim; Martin Görner, Clinical Center, Bielefeld; Matthias Mölle, Clinical Center, Dresden; Tim F. Greten, Hannover Medical School, Hannover; and Volker Lakner, Clinical Center, Rostock, Germany.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2014 Aug 10; Vol. 32 (23), pp. 2423-9. Date of Electronic Publication: 2014 Jun 30.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Pancreatic Neoplasms/*drug therapy, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/pharmacology ; Disease Progression ; Drug Resistance, Neoplasm ; Female ; Fluorouracil/administration & dosage ; Fluorouracil/adverse effects ; Humans ; Leucovorin/administration & dosage ; Leucovorin/adverse effects ; Male ; Middle Aged ; Organoplatinum Compounds/administration & dosage ; Organoplatinum Compounds/adverse effects ; Oxaliplatin ; Pancreatic Neoplasms/pathology ; Survival Analysis ; Treatment Outcome ; Gemcitabine